The Continual Search for Biomarkers - Cancer, Cardiovascular, Immunology, Infectious Diseases and Neurological Diseases

Biomarkers are a highly dynamic space within life science characterized by individual progression through discovery; validation; initial standardized applications in preclinical studies and clinical trials; and incorporation into clinically approved in vitro diagnostic (IVD) assays. In addition to vertical movement, individual biomarkers can be viewed in a horizontal manner across the spectrum of applicable diseases. This spectrum of biomarker usage is encompassed in Kalorama Information’s The G...


Search for Biomarkers Crucial to Neurodegenerative Disease Therapeutics and Diagnostics

Search for Biomarkers Crucial to Neurodegenerative Disease Therapeutics and Diagnostics

Kalorama Information offers related market research titles with Proteomics Markets (research and clinical markets ), Proteomics Research Markets and The Global Market for Biomarkers.

The debilitating neurodegenerative diseases Alzheimer’s and Parkinson’s have vexed healthcare in terms of both therapy and definitive antemortem diagnosis. The localized nature of the diseases in the central nervous system (CNS) makes the development of in vitro diagnostic (IVD) tests difficult. An incomplete unde...


Alzheimer’s Disease Assays Target Clinical Trial Markets First

Alzheimer’s Disease Assays Target Clinical Trial Markets First

Outside of the $50+ billion clinical in vitro diagnostics (IVD) market , analytical instruments and lab diagnostics find major applications in the discovery of clinically significant biomarkers, therapeutics development, and other life sciences research activities. Entire classes of assays are originally developed to validate biomarkers as surrogate endpoints for disease, or as mechanism targets for drug development. The potential of pre-clinical assay markets is not lost to Amarantus BioScience...